Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 1

Status

Completed 5

Sponsor Class

INDUSTRY 3UNKNOWN 1OTHER 1

Study Type

Interventional 5

Sponsor

Conditions

Pain 10Neoplasms 9Marijuana Abuse 5Cancer Pain 5Glioblastoma 2Squamous Cell Carcinoma of Head and Neck 1Signs and Symptoms 1Recurrence 1Parasomnias 1Pancreatic Neoplasms 1Neuralgia 1Nausea 1Multiple Sclerosis 1Mouth Neoplasms 1Marijuana Use 1Diabetes Mellitus 1Chronic Pain 1Cachexia 1Breast Neoplasms 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1Advanced Malignant Solid Tumor 1Advanced Cancer 11- Cancer Patients During Chemotherapy Treatment 1

Interventions

Morphine 16Oxycodone 14Fentanyl 10Methadone 7nabiximols 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Hydromorphone 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Buprenorphine 3Transcranial Direct Current Stimulation 2Tapentadol 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiosurgery 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Cancer Pain × nabiximols × Clear all
NCT05663346 2025-02-14

Cannabis and Cancer, an Online Training for Oncology Nurses

Ciusss de L'Est de l'Île de Montréal

Phase NA Completed
70 enrolled

Cancer Pain, Signs and Symptoms

NCT01337089 2023-04-12

Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Jazz Pharmaceuticals

Phase 3 Completed
660 enrolled 9 charts

Cancer Pain, Pain

NCT01361607 2023-04-12

SPRAY III

Jazz Pharmaceuticals

Phase 3 Completed
399 enrolled 17 charts

Cancer Pain, Pain

NCT01424566 2023-04-12

A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer

Jazz Pharmaceuticals

Phase 3 Completed
406 enrolled 16 charts

Cancer Pain, Pain

NCT01262651 2018-04-23

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

GWPharm

Phase 3 Completed
397 enrolled 18 charts

Cancer Pain, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡